Visit CONTRACT PHARMA at Booth 1163

UPM Appoints Quality Control VP


Dixon to oversee Analytical Testing & Development groups and Microbiological & Raw Material Testing Labs

Daniel Dixon has been appointed vice president of Quality Control, UPM Pharmaceuticals. Mr. Dixon will oversee UPM's Analytical Testing & Development groups and the Microbiological & Raw Material Testing Labs.

Chris Curtin, chief operating officer of UPM Pharmaceuticals said, "Daniel brings a wealth of experience and enthusiasm to this key position at UPM. With his diverse experience in Research, Analytical Testing, Manufacturing and Quality Assurance, I am quite confident that Daniel will enhance and continue to grow our Quality Control Laboratory systems and Analytical capabilities."

Mr. Dixon's experience includes diverse projects throughout the product lifecycle, research, manufacturing and quality assurance; holding advanced positions after serving in the U.S. Army Medical Division. This experience encompasses both pharmaceutical and medical device regulated testing and manufacture; and he is the co-inventor on six patents. Dixon also served in advanced QC/QA positions for Colgate Palmolive and Dentsply Sirona.

Jim Gregory, chief executive officer of UPM Pharmaceuticals said, "With a rich background in both Pharmaceutical Chemistry and Quality Assurance, Daniel brings a unique set of skills and insight to our company. We are confident in Daniel's abilities to optimize our labs and further position UPM as a leader in the CDMO space."